← Eichor
Study identifier: NCT07357051 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

Condition: Respiratory Viral Infection  ·  Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd

PhasePhase 3
Planned participants177
Who can joinAll sexes, 2 Years to 11 Years
Healthy volunteersNo

About this study

The goal of this phase III study is to learn if JKN2301 Dry Suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years.

This description comes directly from the study's public registry record.

Talk to the study team

Ying Yang  ·  +86-0755-33268688  ·  overseas@joincare.com

Always discuss trial participation with your own doctor first.

Locations (1)

First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07357051